Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mologen AG
DescriptionNon-viral DNA expression vector encoding tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionGene therapy; Immunotherapy
Therapeutic ModalityGene therapy: Non-viral vector
Latest Stage of DevelopmentPhase I
Standard IndicationMelanoma
Indication DetailsTreat malignant melanoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today